Dianthus Therapeutics, Inc.

DNTH ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Apr 6, 2023 8-K
8-K Mar 31, 2023 8-K
8-A12B Mar 31, 2023 8-A12B
10-K Mar 23, 2023 10-K
SC 13G/A Feb 14, 2023 SC 13G/A
SC 13G/A Feb 14, 2023
SC 13G/A Feb 14, 2023
SC 13G/A Feb 14, 2023 SC 13G/A
SC 13G/A Feb 14, 2023
SC 13G Feb 13, 2023
4 Feb 9, 2023 FORM 4 SUBMISSION
8-K Feb 7, 2023 8-K
8-K Feb 2, 2023 8-K
8-K Jan 25, 2023 8-K
8-K Dec 20, 2022 8-K
8-K Dec 13, 2022 8-K
4 Dec 2, 2022 FORM 4 SUBMISSION
4 Dec 2, 2022 FORM 4 SUBMISSION
4 Dec 2, 2022 FORM 4 SUBMISSION
4 Dec 2, 2022 FORM 4 SUBMISSION
4 Dec 2, 2022 FORM 4 SUBMISSION
10-Q Nov 3, 2022 10-Q
8-K Nov 3, 2022 8-K
SC 13G/A Sep 27, 2022 SC 13G/A
SC 13G Sep 26, 2022 SC 13G
← Newer Page 13 of 27 · 661 filings Older →